Compare NXP Semiconductors N.V. Common Stock (NXPI) vs Relay Therapeutics Inc. Common Stock (RLAY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
NXP Semiconductors N.V. Common Stock vs Relay Therapeutics Inc. Common Stock — how do they compare? NXP Semiconductors N.V. Common Stock trades at $226.35 (market cap $58.27B), while Relay Therapeutics Inc. Common Stock trades at $18.24 (market cap $3.82B). The key difference: NXP Semiconductors N.V. Common Stock is far larger — about 15.3× Relay Therapeutics Inc. Common Stock's market cap, and NXP Semiconductors N.V. Common Stock pays a 1.76% dividend while Relay Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold NXP Semiconductors N.V. Common Stock for 0 Days and Relay Therapeutics Inc. Common Stock for 0 Days on average.
| NXPI | RLAY | |
|---|---|---|
Market Cap | $58.27B | $3.82B |
Volume | 3,950,702 | 4,332,079 |
Sector | Technology | Health |
52-Week High | $332.67 | $20.75 |
52-Week Low | $184.19 | $6.03 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $66.38B | $2.93B |
Dividend Yield | 1.76% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About NXP Semiconductors N.V. Common Stock
NXP Semiconductors designs semiconductor solutions for embedded applications. Its products serve automotive, industrial and IoT, mobile, and communications-infrastructure markets.
Read more on NXPI →About Relay Therapeutics Inc. Common Stock
Relay Therapeutics develops precision medicines for oncology and genetic diseases. Its drug discovery platform studies how protein motion affects drug targets to guide small-molecule medicine design.
Read more on RLAY →
